病例260:双侧原位肺移植后10个月出现咳嗽及阻塞性通气功能障碍
31岁女性,因囊性纤维化行双侧原位肺移植后10个月,因咳嗽1个月就诊,无发热,肺功能提示新发阻塞性通气障碍(FEV1/FVC 64%),痰培养曾见铜绿假单胞菌和耐甲氧西林金黄色葡萄球菌,支气管镜无活动性感染证据,行胸部X线、CT及18F-FDG PET/CT检查。
要点
- 肺移植后患者出现新发咳嗽和阻塞性通气功能障碍时,需考虑慢性肺移植物功能障碍等并发症。
- 痰培养出的铜绿假单胞菌和耐甲氧西林金黄色葡萄球菌需结合支气管镜结果鉴别定植与感染。
- 影像学检查(X线、CT、PET/CT)用于评估肺移植后肺部及气道并发症。
核心结论
- 肺移植后10个月出现咳嗽、新发阻塞性通气功能障碍,支气管镜无活动性感染,痰培养细菌可能为定植,需影像学进一步评估。
研究设计与样本
- 病例报告,1例31岁女性双侧原位肺移植后患者,行胸部后前位及侧位X线摄影、胸部CT和18F-FDG PET/CT检查。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
History A 31-year-old woman with a history of bilateral orthotopic lung transplantation performed 10 months earlier for cystic fibrosis presented for a routine follow-up appointment, with her chief symptom being a cough. The cough started approximately 1 month prior to this appointment and was minimally productive of clear to yellow phlegm. In addition to her cough, she reported increased sinus congestion and a sensation of "something in her upper chest." She denied shortness of breath, wheezing, hemoptysis, or cigarette smoking. Review of systems was negative for fever, chills, or night sweats. At physical examination, the patient was afebrile, borderline tachycardic (heart rate, 99 beats per minute), and mildly hypertensive (blood pressure, 138/99 mm Hg). Oxygen saturation was 96% on room air. Laboratory evaluation revealed a white blood cell count of 3.5 × 109/L (normal range, 3.2-9.8 × 109/L). Pulmonary function testing was notable for a newly decreased ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) of 64% (2.0 and 3.4 L, respectively) (normal FEV1-to-FVC ratio, 80%), suggesting an obstructive lung process. One month prior to presentation, the patient's sputum cultures grew Pseudomonas and methicillin-resistant Staphylococcus aureus. The patient showed no evidence of active infection at the time of bronchoscopy. Thus, the bacteria were favored to reflect colonization, and antibiotic therapy was not administered at that time. The patient was taking an immunosuppression regimen of mycophenalate mofetil (CellCept; Genentech, San Francisco, Calif) (1 g twice daily), prednisone (10 mg daily), and tacrolimus (Prograf; Astellas Pharma US, Northbrook, Ill) (goal therapeutic range, 12-14 ng/mL). The patient was sent for posteroanterior and lateral chest radiography followed by chest CT ( Figs 1 - 3 ) and fluorine 18 fluorodeoxyglucose PET/CT ( Fig 4 ). [Figure: see text][Figure: see text][Figure: see text][Figure: see text].
引用
- Short RG, Tailor TD. Case 260. Radiology. 2018. PMID: 30020871. doi:10.1148/radiol.2018161559
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。